SR

Sreenivasa Rao Pasupuleti

Active Director Director DIN 09031921
DIN 09031921 First appointment Jan 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Sreenivasa Rao Pasupuleti

Data last updated:

Sreenivasa Rao Pasupuleti is a Director at Pkn Life Sciences Private Limited (since 2021). The company operates in Chemicals.

DIN 09031921
Primary Designation Director
Industry Chemicals
First Appointment 15 Jan 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pkn Life Sciences Private Limited U24299AP2021PTC117119
Director15 Jan 20212021Active

Board colleagues of Sreenivasa Rao Pasupuleti

NameDINCompanyDesignation
Mohana Preethi Bethu09031922Pkn Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pkn Life Sciences Private Limited
Premium access

Shareholding and investment profile for Sreenivasa Rao Pasupuleti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sreenivasa Rao Pasupuleti

Sreenivasa Rao Pasupuleti currently holds 1 directorship: Pkn Life Sciences Private Limited (Director, since 15 Jan 2021).

Sreenivasa Rao Pasupuleti was first appointed on 15 Jan 2021 as Director at Pkn Life Sciences Private Limited.

The current boards of Sreenivasa Rao Pasupuleti's companies include Mohana Preethi Bethu (Pkn Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available